Elevate
- Product NDC
- 43742-0939
- Requested package NDC
- 43742-0939-1
- 11-digit product format
- 437420939
- Labeler code
- 43742
- Product ID
- 43742-0939_26c4d580-0abd-4c60-9fcd-0e6b4408b281
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lycopodium Clavatum, Natrum Muriaticum, Sepia, Belladonna, Causticum, Phosphorus, Sulphur, 5-Hydroxytryptophan, Alumina, Silicea, Acetylcholine Chloride, Dopamine Hydrochloride, Norepinephrine, Phenylethylamine (Hydrochloride), Serotonin (Hydrochloride), Adenosinum Cyclophosphoricum, Cerebrum (Suis), Diencephalon (Suis), Funiculus Umbilicalis Suis, Pantothenic Acid, Pineal Gland (Suis), Sarcolacticum Acidum, Faecalis (Alkaligenes), Gaertner Bacillus (Bach), Proteus (Vulgaris)
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Deseret Biologicals, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2016-11-29
- Marketing end
- 2022-05-23
- Substance
- LYCOPODIUM CLAVATUM SPORE; SODIUM CHLORIDE; SEPIA OFFICINALIS JUICE; ATROPA BELLADONNA; CAUSTICUM; PHOSPHORUS; SULFUR; OXITRIPTAN; ALUMINUM OXIDE; SILICON DIOXIDE; ACETYLCHOLINE CHLORIDE; DOPAMINE HYDROCHLORIDE; NOREPINEPHRINE; PHENETHYLAMINE HYDROCHLORIDE; SEROTONIN HYDROCHLORIDE; ADENOSINE CYCLIC PHOSPHATE; SUS SCROFA CEREBRUM; SUS SCROFA DIENCEPHALON; SUS SCROFA UMBILICAL CORD; PANTOTHENIC ACID; SUS SCROFA PINEAL GLAND; LACTIC ACID, L-; ALCALIGENES FAECALIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; PROTEUS VULGARIS
- Active strength
- 3 [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 43742-0939 | 43742-0939-1 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 43742-0939-1 | 43742093901 | 30 mL in 1 BOTTLE, DROPPER (43742-0939-1) | 30 ml | 2016-11-29 | 2022-05-23 | No | No | Current |